Skip to main content
See every side of every news story
Published loading...Updated

Weight-loss drugs cut alcohol intake by almost two-thirds, research in Ireland suggests

  • A team of researchers in Dublin led by a professor from University College Dublin examined 262 obese adults who were treated with GLP-1 medications over a period of four months.
  • They investigated alcohol consumption due to anecdotal reports of reduced drinking during weight-loss treatments with GLP-1 analogs like liraglutide and semaglutide.
  • The study found average weekly alcohol intake fell from 11.3 to 4.3 units, a nearly two-thirds decrease, with regular drinkers reducing from 23.2 to 7.8 units.
  • Professor le Roux noted the 68% reduction was comparable to nalmefene, an approved European alcohol disorder drug, and patients described the effect as 'effortless'.
  • While the exact mechanism remains under study, the findings suggest GLP-1 medications may curb alcohol cravings and offer a potential treatment for alcohol use disorder pending larger trials.
Insights by Ground AI
Podcasts & Opinions

20 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 45% of the sources are Center
45% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Friday, May 9, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal